Robert Galema
Director/Board Member at EclecticIQ BV
Net worth: - $ as of 2024-05-30
Network origin in Robert Galema first degree
Entity | Entity type | Industry | |
---|---|---|---|
INKEF Capital BV
INKEF Capital BV Investment ManagersFinance INKEF Capital BV is an Independent Venture Capital firm founded in 2010 by Frank R Landsberger. INKEF Capital BV is headquartered in Amsterdam.
24
| Private Company | Investment Managers | 24 |
EclecticIQ BV
EclecticIQ BV Information Technology ServicesTechnology Services EclecticIQ BV develops cyber threat intelligence platform. The company was founded by Joep Gommers and Raymon van der Velder in 2014 and is headquartered in Amsterdam, the Netherlands.
6
| Holding Company | Information Technology Services | 6 |
Aito BV
Aito BV Information Technology ServicesTechnology Services Aito BV provides piezo touch user interface technology. It offers touch solutions on real physical user interfaces with buttons, touch pads, and screens. The firm's products include touch demos that recognize a human touch through various overlay materials, including stainless steel, aluminum, wood, and polycarbonate with back light; whole switching units with injection molded housing, electronic design, and touch user interfacing; aluminum and steel amplifier touch devices. The company was founded by Rene de Vries, Pauli Laitinen and Jockum Lonnberg in 2012 and is headquartered in EJ Amsterdam, the Netherlands.
4
| Holding Company | Information Technology Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Robert Galema via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
UNITED PARCEL SERVICE INC. | Air Freight/Couriers | Director/Board Member | |
ROYAL KPN N.V. | Major Telecommunications | President Corporate Officer/Principal | |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Analyst | |
Nyenrode Business Universiteit | College/University | Graduate Degree | |
TRANSLATE BIO, INC. | Biotechnology | Director/Board Member | |
Johnson & Johnson Innovation - JJDC, Inc.
Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investment Managers | Private Equity Investor | |
NIBC Principal Investments BV
NIBC Principal Investments BV Investment ManagersFinance NIBC Principal Investments BV (Principal Investments) is a subsidiary of NIBC Bank NV, ultimately owned by Kaupthing Bank HF (RE: KAUP) in Iceland. Established in 2003, Principal Investments is a private equity firm which provides mezzanine and private equity financing to companies in Western Europe, particularly in the Benelux countries, Germany and the UK. The firm's activities include direct investments, providing capital for mid-cap companies in Western Europe as well as in real estate and infrastructure projects in Western Europe. They invest as a limited partner in funds managed by NIBC and third parties. | Investment Managers | Private Equity Investor | |
Wellcome Trust Technology Transfer
Wellcome Trust Technology Transfer Investment ManagersFinance Wellcome Trust Technology Transfer (Wellcome Trust Technology Transfer) is a venture capital subsidiary of The Wellcome Trust Ltd. founded in 1992 by Graham Eric Fagg. The firm is headquartered in London. | Investment Managers | Private Equity Analyst | |
The University of Nottingham | College/University | Doctorate Degree | |
University of Leiden | College/University | Graduate Degree Undergraduate Degree | |
University of Utrecht | College/University | Graduate Degree Graduate Degree | |
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member | |
Canbex Therapeutics Ltd.
Canbex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Canbex Therapeutics Ltd. engages in the development of novel peripherally-acting cannabinoid agonists and mimetics for the treatment of multiple sclerosis spasticity and pain. Its lead drug candidate, VSN 16, has been established as a potent, stable and orally-available agonist of GPR-55 with a clear anti-spasticity effect in a validated preclinical model. The company was founded by David Baker, Gavin Giovannoni, Cristina Visintin, Gareth Pryce and David Lawrence Selwood in 2005 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Holland Private Equity BV
Holland Private Equity BV Investment ManagersFinance Holland Private Equity BV is a private equity and venture capital firm. The firm was founded in 2008 by Tim van Delden and Hans van Ierland. It’s headquartered in Amsterdam, the Netherlands. | Investment Managers | President President | |
InteRNA Technologies BV
InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member | |
Convent Capital Management BV
Convent Capital Management BV Investment ManagersFinance Convent Capital Management BV is an independent private equity firm with its headquarters in Amsterdam, the Netherlands. It was founded in 2011. | Investment Managers | Director of Investments | |
Advent Life Sciences LLP
Advent Life Sciences LLP BiotechnologyHealth Technology Part of Advent Venture Partners LLP, Advent Life Sciences LLP is a venture capital firm for visionary innovators. The company is based in London, UK. Advent Life Sciences has achieved its first discovery milestone in collaboration with Bristol Myers Squibb, and is focused on the journey from innovative science to an approved medicine or product. The British company has a history of delivering value and is one of the leading venture capital firms in the industry. | Biotechnology | Private Equity Analyst | |
icometrix NV
icometrix NV Packaged SoftwareTechnology Services icometrix NV provides software as a service for medical image analysis. It engages in the advanced quantitative image processing of human as well as animal data sets, including multi-modal and multi-subject image registration (PET/CT, PET/MR, and CT/MR), volumetric measurements, group analysis of diffusion weighted and tensor images, functional MRI, perfusion MRI, MR spectroscopy, atrophy measurement, automatic and semi-automatic tissue segmentation. The company was founded by Dirk Loeckx, Wim Van Hecke, Paul Suetens, Stefan Sunaert, Paul M. Parizel, Frederik Maes and Jan Sijbers in 2011 and is headquartered in Leuven, Belgium. | Packaged Software | Director/Board Member | |
Asceneuron SA
Asceneuron SA Pharmaceuticals: MajorHealth Technology Asceneuron SA operates as a biotechnology company. It develops therapeutics for orphan tauopathis and Alzheimer?s disease. The firm specializes in small molecule drug discovery for neurodegenerative diseases. The company was founded by Dirk Beher, Frank Murdoch Armstrong and Christoph Wiessner in October 2012 and is headquartered in Lausanne, Switzerland. | Pharmaceuticals: Major | Chairman | |
Pulmocide Ltd.
Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Tiber Creek Partners LLC | Consultant / Advisor | ||
Metabomed Ltd.
Metabomed Ltd. Pharmaceuticals: MajorHealth Technology Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Calypso Biotech SA
Calypso Biotech SA Pharmaceuticals: MajorHealth Technology Calypso Biotech SA operates as a innovative biopharmaceutical company for gastrointestinal immunological disorders. The company was founded by Alain Vicari and Yolande Chvatchko in 2013 and is headquartered in Plan-les-Ouates, Germany. | Pharmaceuticals: Major | Director/Board Member | |
The Wellcome Trust Ltd. (Investment Management)
The Wellcome Trust Ltd. (Investment Management) Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. (Investment Management) (Wellcome-IM) is the investment management division of The Wellcome Trust Ltd., a politically and financially independent global charitable foundation headquartered in London, UK. The Wellcome Trust was founded in 1936, in accordance with Henry Wellcome’s will, to improve health by supporting scientific research and the study of medicine. Funding for this mission came from the profits of the pharmaceutical business he had built up over 50 years. Wellcome-IM manages The Wellcome Trust. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
GTX medical BV
GTX medical BV BiotechnologyHealth Technology GTX medical BV engages in the development of medical devices for targeted epidural spinal stimulation therapy. The company was founded by Jocelyne Bloch, Sjaak Deckers, and Grégoire Courtine in December 2014 and is headquartered in Eindhoven, the Netherlands. | Biotechnology | Director/Board Member | |
NMD Pharma A/S
NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Director/Board Member Director/Board Member | |
Merck Ventures BV
Merck Ventures BV Investment ManagersFinance Merck Ventures BV (Merck Ventures) is a venture capital arm of Merck KGaA founded in 2009. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Analyst Private Equity Analyst | |
Varmx BV
Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Director/Board Member | |
EIT Digital IVZW
EIT Digital IVZW Information Technology ServicesTechnology Services EIT Digital IVZW is a digital innovation and entrepreneurial education organization that supports the creation of a competitive and sustainable digital world. The private company builds the next generation of digital ventures, products, and services, and breed digital entrepreneurial talent, helping businesses and entrepreneurs to be at the forefront of digital innovation. The company is based in Brussels, Belgium, and has subsidiaries in Belgium. The Belgian company mobilizes a multi-stakeholder open-innovation ecosystem of top corporations, SMEs, startups, universities, and research institutes to address the technology, talent, skills, business, and capital needs of digital entrepreneurship. The CEO of the company is Willem Jonker. | Information Technology Services | Director/Board Member | |
Arrakis Therapeutics, Inc.
Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder | |
Scenic Biotech BV
Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
iOnctura SA
iOnctura SA Miscellaneous Commercial ServicesCommercial Services iOnctura SA is a pre-clinical stage biopharmaceutical company focused on the research and development of novel immuno-oncology therapeutics for patients fighting cancer. The company was founded in June 2017 and is headquartered in Geneve, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Syndesi Therapeutics SA
Syndesi Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Ciwit BV
Ciwit BV Internet Software/ServicesTechnology Services Ciwit BV provides electronic data capture platform for medical research. The company was founded by Derk Arts in 2011 and is headquartered in Amsterdam, the Netherlands. | Internet Software/Services | Director/Board Member Director/Board Member | |
Scaled Access NV
Scaled Access NV Packaged SoftwareTechnology Services Scaled Access NV engages in the provision of cloud-based solution access control platform. It specializes in role-based access, offline sessions, appliance registration, access to streamed content, and identity-aware smart devices. The company was founded by Carlo Schüpp and Ward Duchamps in 2010 and is headquartered in Leuven, Belgium. | Packaged Software | Director/Board Member | |
Calypso Biotech BV
Calypso Biotech BV BiotechnologyHealth Technology Calypso Biotech BV operates as immunotherapy biotech company. It develops monoclonal antibodies for the treatment of immune pathologies with large unmet medical needs. The company was founded by Alain Vicari and Yolande Chvatchko in 2013 and is headquartered in Amsterdam, the Netherlands. | Biotechnology | Director/Board Member | |
Mestag Therapeutics Ltd.
Mestag Therapeutics Ltd. Financial ConglomeratesFinance Mestag Therapeutics Ltd. is engaged in the biotechnology industry. The company was founded on February 17, 2020 and is headquartered in Cambridge, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Apollo Therapeutics LLP
Apollo Therapeutics LLP Financial ConglomeratesFinance Apollo Therapeutics LLP is a British biopharmaceutical company that focuses on translating medical research into medicines. The company is based in Stevenage, UK. The company has a portfolio-model built around a centralized management team of experts in pharmaceutical R&D, manufacturing, commercial strategy, fundraising, and business development. The company's assets are housed in separate wholly-owned subsidiary companies, which incorporate best practices from big pharma and venture capital. The company has a scalable R&D platform for the discovery and development of new medicines, enabled by access to five of the world's leading universities and research institutes. The company was founded in 2015, and the CEO is Richard Mason. | Financial Conglomerates | Consultant / Advisor | |
ONWARD MEDICAL N.V. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Kersten Elektrotechniek BV
Kersten Elektrotechniek BV Engineering & ConstructionIndustrial Services Kersten Elektrotechniek BV is a Dutch company that specializes in engineering, realization, prefab, project management, and management of complete installations. The private company is based in Elst, Netherlands. The company has everything in-house, from design and engineering to project management and technical management, which allows them to complete installations with their partners. The CEO of the company is Jan Pieter Manschot. | Engineering & Construction | Director/Board Member | |
Castor /US/
Castor /US/ Data Processing ServicesTechnology Services Castor is a clinical data management company based in New York, NY. Castor provides a range of electronic solutions for clinical trials, including EDC, ePRO, eCOA, IWRS, CDMS, and decentralized trial solutions, all on a single platform. The company was founded by Derk Arts, who has been the CEO since incorporation. | Data Processing Services | Director/Board Member | |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
Netherlands | 18 |
United Kingdom | 13 |
United States | 11 |
Switzerland | 6 |
Belgium | 5 |
Sectoral
Health Technology | 20 |
Finance | 10 |
Commercial Services | 7 |
Technology Services | 6 |
Consumer Services | 5 |
Operational
Director/Board Member | 95 |
Private Equity Investor | 33 |
Corporate Officer/Principal | 23 |
Chief Executive Officer | 17 |
Graduate Degree | 12 |
Most connected contacts
- Stock Market
- Insiders
- Robert Galema
- Company connections